ArticleAddiction (Abingdon, England)2025
Age-period-cohort analysis of past 12-month cannabis use in Germany (1995-2021).
Article in Addiction (Abingdon, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Childhood events as factors in continued cannabis use in adulthood: a longitudinal study of a 30-year follow-up cohort.Journal of cannabis research · 2025Article
- Age-period-cohort analysis of past 12-month cannabis use in Germany (1995-2021).Addiction (Abingdon, England) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
BACKGROUND AND
aimsIn 2024, cannabis was partially legalized for recreational purposes in Germany. With a growing prevalence of persons who used cannabis in the past 12 months, and the health risks associated with cannabis use, it is imperative to examine usage behavior patterns in greater detail. The present analysis measured the impact of age, time period and birth cohort on the prevalence of cannabis consumption in the past 12 months in Germany.
designLongitudinal study using data from 10 waves (1995-2021) of the German Epidemiological Survey of Substance Abuse (ESA), a cross-sectional nationally representative household survey of individuals between the ages of 18 and 59 or 64 years.
settingGermany.
participantsN MEASUREMENTS: Self-report of cannabis use in the last 12 months as well as alcohol use and smoking conventional tobacco products in the last 30 days.
findingsWe employed binary logistic regression using a generalized additive model to examine age, period and cohort effects, as well as covariate effects on past 12-month cannabis use. Over time, both period and cohort had an increasing effect, while an increase in age corresponded to a decrease in prevalence. Specifically, the odds ratio (OR) for cannabis use decreased from 9.44 [95% confidence interval (CI) = 8.17-10.9] at age 18 years to 0.13 (95 CI = 0.10-0.17) at age 59 years. Period effects also showed an increase, with the OR rising from 0.33 (95% CI = 0.26-0.43) in 1995 to 2.96 (95% CI = 2.55-3.43) in 2021, while cohort effects increased from 0.02 (95% CI = 0.001-0.05) for those born in 1936 to 16.69 (95% CI = 13.8-20.8) for those born in 2002. Additionally, persons using cannabis had a higher likelihood of also drinking alcohol and smoking conventional tobacco products in the last 30 days.
conclusionsIn Germany, the odds of being a past-12-month cannabis consumer appears to decline with increasing age, indicating that only a small proportion of consumers engage in cannabis use throughout their whole lives, with a peak prevalence occurring at a younger age.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.